arXiv:2508.00383cs.CVcs.AI2025-08中稿 · ed被引 1

用混合模型提升病理图像预测基因表达的准确率和稳定性。

$MV_{Hybrid}$: Improving Spatial Transcriptomics Prediction with Hybrid State Space-Vision Transformer Backbone in Pathology Vision Foundation Models

  • 融合状态空间模型与ViT,捕捉细微形态特征。
  • 在留一研究评估中相关性比最优ViT高57%。
  • 适合需要高精度基因预测的病理研究者使用。

空间转录组学揭示组织背景下的基因表达模式,支持精准肿瘤学中的治疗响应预测等应用,但其高昂成本和技术复杂性限制了临床推广。从常规病理图像预测空间基因表达(生物标志物)提供了实用替代方案,但现有基于视觉变压器(ViT)骨干的病理视觉基础模型(VFMs)性能尚未达到临床标准。鉴于这些模型已在数百万张多样的全切片图像上预训练,我们假设超越ViT的架构创新可能更有效捕捉与分子表型相关的低频、细微形态模式。通过证明初始化为负实特征值的状态空间模型(SSM)具有强低频偏倚,我们提出$MV_{Hybrid}$——一种结合SSM与ViT的混合骨干架构。我们在相同结直肠癌数据集上,使用DINOv2自监督学习方法对五种不同骨干架构进行预训练,并在相同的生物标志物数据集上采用随机划分和留一研究(LOSO)两种设置进行评估。在LOSO评估中,$MV_{Hybrid}$的相关性比最佳ViT高出57%,且性能下降比随机划分小43%,分别体现了卓越的性能和鲁棒性。此外,$MV_{Hybrid}$在分类、切片检索和生存预测任务中表现持平或优于ViT,展现出作为下一代病理视觉基础模型骨干的潜力。代码已公开:https://github.com/deepnoid-ai/MVHybrid。

原文摘要 · Abstract (English)

Spatial transcriptomics reveals gene expression patterns within tissue context, enabling precision oncology applications such as treatment response prediction, but its high cost and technical complexity limit clinical adoption. Predicting spatial gene expression (biomarkers) from routine histopathology images offers a practical alternative, yet current vision foundation models (VFMs) in pathology based on Vision Transformer (ViT) backbones perform below clinical standards. Given that VFMs are already trained on millions of diverse whole slide images, we hypothesize that architectural innovations beyond ViTs may better capture the low-frequency, subtle morphological patterns correlating with molecular phenotypes. By demonstrating that state space models initialized with negative real eigenvalues exhibit strong low-frequency bias, we introduce $MV_{Hybrid}$, a hybrid backbone architecture combining state space models (SSMs) with ViT. We compare five other different backbone architectures for pathology VFMs, all pretrained on identical colorectal cancer datasets using the DINOv2 self-supervised learning method. We evaluate all pretrained models using both random split and leave-one-study-out (LOSO) settings of the same biomarker dataset. In LOSO evaluation, $MV_{Hybrid}$ achieves 57% higher correlation than the best-performing ViT and shows 43% smaller performance degradation compared to random split in gene expression prediction, demonstrating superior performance and robustness, respectively. Furthermore, $MV_{Hybrid}$ shows equal or better downstream performance in classification, patch retrieval, and survival prediction tasks compared to that of ViT, showing its promise as a next-generation pathology VFM backbone. Our code is publicly available at: https://github.com/deepnoid-ai/MVHybrid.

病理分析基因预测混合模型

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。